The Clinical Study of CD20 CAR-T Cells in Patients With Relapsed and Refractory B Cell Non-Hodgkin Lymphoma
NCT04169932
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
UNKNOWN
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Relapsed and Refractory B Cell Lymphoma
Non-Hodgkin Lymphoma
Interventions
BIOLOGICAL:
CD20 CAR-T
Sponsor
Shanghai Longyao Biotechnology Inc., Ltd.